Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C025984 |
15-hydroxy-5,8,11,13-eicosatetraenoic acid |
15-hydroxy-5,8,11,13-eicosatetraenoic acid affects the localization of PRKCA protein | affects localization | 15613483
|
C025984 |
15-hydroxy-5,8,11,13-eicosatetraenoic acid |
15-hydroxy-5,8,11,13-eicosatetraenoic acid promotes the reaction [EGF protein affects the localization of PRKCA protein] | affects localization|increases reaction | 15613483
|
C025984 |
15-hydroxy-5,8,11,13-eicosatetraenoic acid |
15-hydroxy-5,8,11,13-eicosatetraenoic acid promotes the reaction [HGF protein affects the localization of PRKCA protein] | affects localization|increases reaction | 15613483
|
C025984 |
15-hydroxy-5,8,11,13-eicosatetraenoic acid |
15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased activity of PRKCA protein | increases activity | 15451026
|
C025984 |
15-hydroxy-5,8,11,13-eicosatetraenoic acid |
calphostin C inhibits the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased activity of PRKCA protein] | decreases reaction|increases activity | 15451026
|
C060229 |
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione |
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione promotes the reaction [Corticosterone results in increased activity of PRKCA protein] | increases activity|increases reaction | 16581232
|
C014024 |
2,4,5,2',4',5'-hexachlorobiphenyl |
2,4,5,2',4',5'-hexachlorobiphenyl results in increased activity of PRKCA protein | increases activity | 16263226
|
C014024 |
2,4,5,2',4',5'-hexachlorobiphenyl |
2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of PRKCA protein | increases expression | 16263226
|
C028451 |
3,4,3',4'-tetrachlorobiphenyl |
3,4,3',4'-tetrachlorobiphenyl results in increased activity of PRKCA protein | increases activity | 16263226
|
C028451 |
3,4,3',4'-tetrachlorobiphenyl |
3,4,3',4'-tetrachlorobiphenyl results in increased expression of PRKCA protein | increases expression | 16263226
|
C002385 |
3-morpholino-sydnonimine |
[3-morpholino-sydnonimine co-treated with Staurosporine] results in decreased expression of PRKCA protein | affects cotreatment|decreases expression | 11994256
|
C002385 |
3-morpholino-sydnonimine |
Staurosporine inhibits the reaction [3-morpholino-sydnonimine results in increased phosphorylation of PRKCA protein] | decreases reaction|increases phosphorylation | 11994256
|
C088860 |
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline |
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [EGF protein affects the localization of PRKCA protein] | affects localization|decreases reaction | 15613483
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of PRKCA mRNA | affects expression | 21346803
|
C059539 |
4'-N-benzoylstaurosporine |
4'-N-benzoylstaurosporine results in decreased activity of PRKCA protein | decreases activity | 15542774
|
C058206 |
6-chloro-3,5-diaminopyrazine-3-carboxamide |
6-chloro-3,5-diaminopyrazine-3-carboxamide results in decreased expression of PRKCA protein | decreases expression | 12225976
|
D000255 |
Adenosine Triphosphate |
[[Adenosine Triphosphate co-treated with PRKCA protein] results in increased phosphorylation of RALBP1 protein] which results in increased transport of Doxorubicin | affects cotreatment|increases phosphorylation|increases transport | 16087181
|
C096920 |
AGN 193109 |
AGN 193109 inhibits the reaction [Tretinoin results in increased expression of PRKCA mRNA] | decreases reaction|increases expression | 16505366
|
D000450 |
Aldosterone |
Aldosterone results in decreased expression of PRKCA protein | decreases expression | 12225976
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PRKCA mRNA | affects expression | 16483693
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in decreased expression of PRKCA protein | decreases expression | 16483693
|
D000661 |
Amphetamine |
Amphetamine results in increased expression of PRKCA mRNA | increases expression | 16101753
|
D000661 |
Amphetamine |
PRKCA protein promotes the reaction [Amphetamine results in decreased expression of NPY mRNA] | decreases expression|increases reaction | 16101753
|
D000661 |
Amphetamine |
PRKCA protein results in increased susceptibility to Amphetamine | increases response to substance | 16101753
|
C028617 |
aroclor 1248 |
aroclor 1248 results in increased activity of PRKCA protein | increases activity | 16263226
|
C028617 |
aroclor 1248 |
aroclor 1248 results in increased expression of PRKCA protein | increases expression | 16263226
|
C028617 |
aroclor 1248 |
aroclor 1248 results in increased transport of PRKCA protein | increases transport | 16263226
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased activity of PRKCA protein | increases activity | 12626342
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of PRKCA protein | increases expression | 12626342
|
D001280 |
Atrazine |
Atrazine results in increased expression of PRKCA mRNA | increases expression | 18585445
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of PRKCA mRNA | decreases expression | 20064835 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PRKCA mRNA | decreases expression | 19150397
|
C477843 |
bicyclol |
bicyclol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PRKCA mRNA] | decreases reaction|increases expression | 17106253
|
C477843 |
bicyclol |
bicyclol inhibits the reaction [Diethylnitrosamine results in increased expression of PRKCA mRNA] | decreases reaction|increases expression | 17106253
|
D001647 |
Bile Acids and Salts |
Bile Acids and Salts promotes the reaction [PRKCA protein results in increased phosphorylation of ABCB11 protein] | increases phosphorylation|increases reaction | 11343252
|
D020001 |
1-Butanol |
[1-Butanol inhibits the reaction [PRKCA protein binds to PLD1 protein]] which results in decreased activity of PLD1 protein | affects binding|decreases activity|decreases reaction | 15652502
|
D020001 |
1-Butanol |
1-Butanol inhibits the reaction [Thapsigargin results in increased localization of PRKCA protein] | decreases reaction|increases localization | 15843515
|
D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene results in decreased expression of PRKCA protein | decreases expression | 7716780
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of PRKCA mRNA | decreases expression | 15336504
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide affects the localization of PRKCA protein | affects localization | 16716901
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased activity of PRKCA protein | increases activity | 16716901
|
D002101 |
Cacodylic Acid |
Cacodylic Acid results in increased expression of PRKCA mRNA | increases expression | 17481689
|
D002118 |
Calcium |
[Tretinoin co-treated with Calcium] results in increased activity of PRKCA protein | affects cotreatment|increases activity | 16114872
|
C058819 |
calphostin C |
calphostin C inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PRKCA protein] | decreases reaction|increases activity | 16091123
|
C058819 |
calphostin C |
calphostin C inhibits the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased activity of PRKCA protein] | decreases reaction|increases activity | 15451026
|
C058819 |
calphostin C |
calphostin C inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCA protein] | affects localization|decreases reaction | 16343552
|
C058819 |
calphostin C |
calphostin C inhibits the reaction [Heptachlor affects the localization of PRKCA protein] | affects localization|decreases reaction | 14678745
|
C058819 |
calphostin C |
calphostin C inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCA protein] | affects localization|decreases reaction | 14678745
|
D002211 |
Capsaicin |
Capsaicin results in increased expression of PRKCA mRNA | increases expression | 18752301
|
D002211 |
Capsaicin |
Capsaicin results in increased expression of PRKCA protein | increases expression | 18752301
|
D002211 |
Capsaicin |
chelerythrine inhibits the reaction [Capsaicin results in increased expression of PRKCA protein] | decreases reaction|increases expression | 18752301
|
D002211 |
Capsaicin |
iodoresiniferatoxin inhibits the reaction [Capsaicin results in increased expression of PRKCA protein] | decreases reaction|increases expression | 18752301
|
C016299 |
chelerythrine |
chelerythrine inhibits the reaction [Capsaicin results in increased expression of PRKCA protein] | decreases reaction|increases expression | 18752301
|
D003345 |
Corticosterone |
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione promotes the reaction [Corticosterone results in increased activity of PRKCA protein] | increases activity|increases reaction | 16581232
|
D003345 |
Corticosterone |
PD 98059 promotes the reaction [Corticosterone results in increased activity of PRKCA protein] | increases activity|increases reaction | 16581232
|
D003474 |
Curcumin |
[PRKCA protein results in increased phosphorylation of CFTR protein] promotes the reaction [Curcumin results in increased activity of CFTR protein] | increases activity|increases phosphorylation|increases reaction | 17178710
|
C004742 |
daidzein |
daidzein results in increased activity of PRKCA protein | increases activity | 16972265
|
D003840 |
Deoxycholic Acid |
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of PRKCA mRNA | affects cotreatment|increases expression | 16556975
|
D003907 |
Dexamethasone |
Dexamethasone affects the expression of PRKCA mRNA | affects expression | 12732289
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of PRKCA mRNA | decreases expression | 18042831
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased phosphorylation of and results in increased activity of PRKCA protein | increases activity|increases phosphorylation | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of and results in increased activity of PRKCA protein] | decreases reaction|increases activity|increases phosphorylation | 17942915
|
D004052 |
Diethylnitrosamine |
bicyclol inhibits the reaction [Diethylnitrosamine results in increased expression of PRKCA mRNA] | decreases reaction|increases expression | 17106253
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of PRKCA mRNA | increases expression | 17106253
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in decreased expression of PRKCA | decreases expression | 17943652
|
D004075 |
Diglycerides |
Diglycerides affects the reaction [Phenylephrine results in increased localization of PRKCA protein] | affects reaction|increases localization | 18487437
|
C472511 |
dimethylarsinous acid |
dimethylarsinous acid results in decreased expression of PRKCA mRNA | decreases expression | 16507463
|
D004317 |
Doxorubicin |
[[Adenosine Triphosphate co-treated with PRKCA protein] results in increased phosphorylation of RALBP1 protein] which results in increased transport of Doxorubicin | affects cotreatment|increases phosphorylation|increases transport | 16087181
|
D004317 |
Doxorubicin |
PRKCA protein affects the reaction [RALBP1 protein affects the transport of and affects the susceptibility to Doxorubicin] | affects reaction|affects response to substance|affects transport | 16579994
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PRKCA mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of PRKCA mRNA | increases expression | 19619570
|
D000431 |
Ethanol |
[Ethanol results in increased localization of and results in increased activity of PRKCA protein] promotes the reaction [Tetradecanoylphorbol Acetate results in increased abundance of Superoxides] | increases abundance|increases activity|increases localization|increases reaction | 10651808
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of PRKCA mRNA | affects expression | 17555576
|
C049347 |
fasudil |
fasudil results in decreased activity of PRKCA protein | decreases activity | 17222050
|
C065382 |
fluticasone |
fluticasone results in decreased expression of PRKCA protein | decreases expression | 15634547
|
D019833 |
Genistein |
Genistein results in increased expression of PRKCA mRNA | increases expression | 16705744
|
C030691 |
gluconic acid |
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of PRKCA mRNA | affects cotreatment|increases expression | 16556975
|
C081021 |
Go 6976 |
Go 6976 results in decreased expression of and results in decreased activity of PRKCA protein | decreases activity|decreases expression | 16374459
|
C081021 |
Go 6976 |
Go 6976 results in decreased expression of PRKCA mRNA | decreases expression | 16374459
|
C081021 |
Go 6976 |
Go 6976 results in decreased phosphorylation of PRKCA protein | decreases phosphorylation | 19393235
|
C081021 |
Go 6976 |
Go 6976 results in decreased activity of PRKCA protein | decreases activity | 15767308
|
D019307 |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Heptachlor affects the localization of PRKCA protein] | affects localization|decreases reaction | 14678745
|
D019307 |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCA protein] | affects localization|decreases reaction | 14678745
|
D006533 |
Heptachlor |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Heptachlor affects the localization of PRKCA protein] | affects localization|decreases reaction | 14678745
|
D006533 |
Heptachlor |
calphostin C inhibits the reaction [Heptachlor affects the localization of PRKCA protein] | affects localization|decreases reaction | 14678745
|
D006533 |
Heptachlor |
Heptachlor affects the localization of and results in increased activity of PRKCA protein | affects localization|increases activity | 14678745
|
D006533 |
Heptachlor |
Staurosporine inhibits the reaction [Heptachlor affects the localization of PRKCA protein] | affects localization|decreases reaction | 14678745
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased activity of PRKCA protein | increases activity | 12626342
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased expression of PRKCA protein | increases expression | 12626342
|
D006861 |
Hydrogen Peroxide |
[Hydrogen Peroxide co-treated with Vanadates] results in increased phosphorylation of [PLD1 protein binds to PRKCA protein] | affects binding|affects cotreatment|increases phosphorylation | 15150437
|
D006861 |
Hydrogen Peroxide |
[Hydrogen Peroxide co-treated with Vanadates] results in increased phosphorylation of PRKCA protein | affects cotreatment|increases phosphorylation | 15150437
|
C078006 |
imidaprilat |
imidaprilat inhibits the reaction [AGT protein results in increased activity of and results in increased localization of PRKCA protein] | decreases reaction|increases activity|increases localization | 16257180
|
C468130 |
iodoresiniferatoxin |
iodoresiniferatoxin inhibits the reaction [Capsaicin results in increased expression of PRKCA protein] | decreases reaction|increases expression | 18752301
|
C051890 |
irinotecan |
irinotecan metabolite results in increased phosphorylation of PRKCA protein | increases phosphorylation | 15723263
|
C051890 |
irinotecan |
irinotecan results in increased phosphorylation of PRKCA protein | increases phosphorylation | 15723263
|
C037642 |
kemptide |
PRKCA protein results in increased metabolism of kemptide | increases metabolic processing | 17222050
|
C063302 |
KN 62 |
KN 62 results in decreased activity of PRKCA protein | decreases activity | 17222050
|
D007854 |
Lead |
Lead results in decreased expression of PRKCA protein | decreases expression | 16547843
|
C008261 |
lead acetate |
lead acetate results in decreased expression of PRKCA protein | decreases expression | 16547843
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides affects the localization of and results in increased activity of PRKCA protein | affects localization|increases activity | 16330529
|
C008493 |
methylselenic acid |
methylselenic acid results in increased expression of PRKCA mRNA | increases expression | 12517777
|
D015741 |
Metribolone |
Metribolone promotes the reaction [EZR protein binds to PRKCA protein] | affects binding|increases reaction | 16873375
|
D015741 |
Metribolone |
PRKCA protein affects the reaction [Metribolone results in increased phosphorylation of EZR protein] | affects reaction|increases phosphorylation | 16873375
|
D015735 |
Mifepristone |
Mifepristone binds to and results in decreased activity of PRKCA protein | affects binding|decreases activity | 16581232
|
C020300 |
monomethylarsonic acid |
monomethylarsonic acid results in increased expression of PRKCA mRNA | increases expression | 17481689
|
C406082 |
monomethylarsonous acid |
monomethylarsonous acid results in decreased expression of PRKCA mRNA | decreases expression | 16507463
|
C063509 |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased activity of PRKCA protein | decreases activity | 16361081
|
C063509 |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased activity of PRKCA protein | decreases activity | 17222050
|
C041786 |
palm oil |
palm oil results in decreased expression of PRKCA mRNA | decreases expression | 18042831
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [EGF protein affects the localization of PRKCA protein] | affects localization|decreases reaction | 15613483
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [HGF protein affects the localization of PRKCA protein] | affects localization|decreases reaction | 15613483
|
C093973 |
PD 98059 |
PD 98059 promotes the reaction [Corticosterone results in increased activity of PRKCA protein] | increases activity|increases reaction | 16581232
|
D010634 |
Phenobarbital |
Phenobarbital affects the expression of PRKCA mRNA | affects expression | 19136022
|
D010656 |
Phenylephrine |
DGKE protein inhibits the reaction [Phenylephrine results in increased localization of PRKCA protein] | decreases reaction|increases localization | 18487437
|
D010656 |
Phenylephrine |
Diglycerides affects the reaction [Phenylephrine results in increased localization of PRKCA protein] | affects reaction|increases localization | 18487437
|
D010656 |
Phenylephrine |
Phenylephrine results in increased localization of PRKCA protein | increases localization | 18487437
|
D010656 |
Phenylephrine |
GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of PRKCA protein] | decreases reaction|increases activity|increases phosphorylation | 16809552
|
D010656 |
Phenylephrine |
Phenylephrine results in increased activity of PRKCA protein | increases activity | 12435817
|
D010656 |
Phenylephrine |
Phenylephrine results in increased phosphorylation of and results in increased activity of PRKCA protein | increases activity|increases phosphorylation | 16809552
|
D015240 |
Phorbol 12,13-Dibutyrate |
Phorbol 12,13-Dibutyrate results in decreased expression of PRKCA protein | decreases expression | 17171646
|
D015240 |
Phorbol 12,13-Dibutyrate |
Phorbol 12,13-Dibutyrate results in increased expression of PRKCA protein | increases expression | 12626342
|
D010703 |
Phorbol Esters |
Phorbol Esters promotes the reaction [PRKCA protein results in increased phosphorylation of ABCB11 protein] | increases phosphorylation|increases reaction | 11343252
|
D010703 |
Phorbol Esters |
Phorbol Esters affects the localization of and results in increased activity of PRKCA protein | affects localization|increases activity | 14679204
|
D010718 |
Phosphatidylserines |
[Tretinoin co-treated with Phosphatidylserines] results in decreased activity of PRKCA protein | affects cotreatment|decreases activity | 16114872
|
C006253 |
pirinixic acid |
pirinixic acid affects the expression of PRKCA mRNA | affects expression | 19136022
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of PRKCA mRNA | increases expression | 12832660
|
D011280 |
Pregnanolone |
Pregnanolone results in decreased expression of PRKCA protein | decreases expression | 16581232
|
D019269 |
Phosphatidylinositol 4,5-Diphosphate |
[Tretinoin co-treated with Phosphatidylinositol 4,5-Diphosphate] results in decreased activity of PRKCA protein | affects cotreatment|decreases activity | 16114872
|
C059514 |
resveratrol |
PRKCA protein affects the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein]] | affects reaction|decreases reaction|increases activity|increases localization|increases phosphorylation | 15542774
|
C059514 |
resveratrol |
PRKCA protein affects the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein]] | affects reaction|decreases reaction|increases activity|increases localization|increases phosphorylation | 15542774
|
C059514 |
resveratrol |
PRKCA protein affects the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]] | affects reaction|decreases reaction|increases activity|increases localization|increases phosphorylation | 15542774
|
C089730 |
rosiglitazone |
rosiglitazone inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCA protein] | affects localization|decreases reaction | 20032081
|
C089730 |
rosiglitazone |
rosiglitazone inhibits the reaction [VEGFA protein affects the localization of PRKCA protein] | affects localization|decreases reaction | 20032081
|
C085746 |
rottlerin |
rottlerin results in decreased activity of PRKCA protein | decreases activity | 17222050
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of PRKCA mRNA | decreases expression | 16507463
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of PRKCA mRNA | increases expression | 12016162
|
D019311 |
Staurosporine |
Staurosporine affects the localization of and affects the activity of PRKCA protein | affects activity|affects localization | 16225760
|
D019311 |
Staurosporine |
[3-morpholino-sydnonimine co-treated with Staurosporine] results in decreased expression of PRKCA protein | affects cotreatment|decreases expression | 11994256
|
D019311 |
Staurosporine |
Staurosporine inhibits the reaction [3-morpholino-sydnonimine results in increased phosphorylation of PRKCA protein] | decreases reaction|increases phosphorylation | 11994256
|
D019311 |
Staurosporine |
Staurosporine inhibits the reaction [Heptachlor affects the localization of PRKCA protein] | affects localization|decreases reaction | 14678745
|
D019311 |
Staurosporine |
Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCA protein] | affects localization|decreases reaction | 14678745
|
D013481 |
Superoxides |
[Ethanol results in increased localization of and results in increased activity of PRKCA protein] promotes the reaction [Tetradecanoylphorbol Acetate results in increased abundance of Superoxides] | increases abundance|increases activity|increases localization|increases reaction | 10651808
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of PRKCA mRNA | affects expression | 17555576
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased phosphorylation of PRKCA protein | decreases phosphorylation | 19393235
|
D020002 |
tert-Butyl Alcohol |
tert-Butyl Alcohol inhibits the reaction [Thapsigargin results in increased localization of PRKCA protein] | decreases reaction|increases localization | 15843515
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PRKCA mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of PRKCA mRNA | decreases expression | 19684285 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PRKCA mRNA | increases expression | 12377990 19684285
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of PRKCA | decreases expression | 17943652
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin binds to AHR protein] which affects the localization of PRKCA protein | affects binding|affects localization | 15761253
|
C117155 |
tetracycline CMT-3 |
tetracycline CMT-3 results in decreased activity of PRKCA protein | decreases activity | 16134060
|
D013755 |
Tetradecanoylphorbol Acetate |
calphostin C inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PRKCA protein] | decreases reaction|increases activity | 16091123
|
D013755 |
Tetradecanoylphorbol Acetate |
[Ethanol results in increased localization of and results in increased activity of PRKCA protein] promotes the reaction [Tetradecanoylphorbol Acetate results in increased abundance of Superoxides] | increases abundance|increases activity|increases localization|increases reaction | 10651808
|
D013755 |
Tetradecanoylphorbol Acetate |
rosiglitazone inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCA protein] | affects localization|decreases reaction | 20032081
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate affects the localization of and results in increased activity of PRKCA protein | affects localization|increases activity | 16091123 15978937
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate affects the localization of PRKCA protein | affects localization | 20032081 15976015
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in decreased expression of PRKCA protein | decreases expression | 17171646
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in decreased phosphorylation of PRKCA protein | decreases phosphorylation | 15380616
|
D013755 |
Tetradecanoylphorbol Acetate |
bicyclol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PRKCA mRNA] | decreases reaction|increases expression | 17106253
|
D013755 |
Tetradecanoylphorbol Acetate |
calphostin C inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCA protein] | affects localization|decreases reaction | 16343552
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate affects the localization of PRKCA protein | affects localization | 16343552
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased expression of PRKCA mRNA | increases expression | 17106253
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased localization of PRKCA protein | increases localization | 10656618
|
D013755 |
Tetradecanoylphorbol Acetate |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCA protein] | affects localization|decreases reaction | 14678745
|
D013755 |
Tetradecanoylphorbol Acetate |
calphostin C inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCA protein] | affects localization|decreases reaction | 14678745
|
D013755 |
Tetradecanoylphorbol Acetate |
Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCA protein] | affects localization|decreases reaction | 14678745
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate affects the localization of PRKCA protein | affects localization | 14678745 14975926 12720544 14736339
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased localization of PRKCA protein | increases localization | 15843515
|
D019284 |
Thapsigargin |
1-Butanol inhibits the reaction [Thapsigargin results in increased localization of PRKCA protein] | decreases reaction|increases localization | 15843515
|
D019284 |
Thapsigargin |
tert-Butyl Alcohol inhibits the reaction [Thapsigargin results in increased localization of PRKCA protein] | decreases reaction|increases localization | 15843515
|
D019284 |
Thapsigargin |
Thapsigargin results in increased localization of PRKCA protein | increases localization | 15843515
|
D013893 |
Thiram |
Thiram results in decreased activity of PRKCA protein | decreases activity | 15998240
|
C080287 |
thymeleatoxin |
thymeleatoxin affects the localization of PRKCA protein | affects localization | 14679204
|
D014212 |
Tretinoin |
PRKCA protein affects the reaction [Tretinoin results in increased activity of STS protein] | affects reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
AGN 193109 inhibits the reaction [Tretinoin results in increased expression of PRKCA mRNA] | decreases reaction|increases expression | 16505366
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of PRKCA mRNA | increases expression | 16505366
|
D014212 |
Tretinoin |
[Tretinoin co-treated with Calcium] results in increased activity of PRKCA protein | affects cotreatment|increases activity | 16114872
|
D014212 |
Tretinoin |
[Tretinoin co-treated with Phosphatidylinositol 4,5-Diphosphate] results in decreased activity of PRKCA protein | affects cotreatment|decreases activity | 16114872
|
D014212 |
Tretinoin |
[Tretinoin co-treated with Phosphatidylserines] results in decreased activity of PRKCA protein | affects cotreatment|decreases activity | 16114872
|
C052920 |
trimethylarsine oxide |
trimethylarsine oxide results in increased expression of PRKCA mRNA | increases expression | 17481689
|
D014415 |
Tunicamycin |
Tunicamycin results in increased expression of PRKCA mRNA | increases expression | 17127020
|
D014520 |
Urethane |
IFNG protein inhibits the reaction [Urethane results in decreased expression of PRKCA mRNA] | decreases expression|decreases reaction | 11091364
|
D014520 |
Urethane |
Urethane results in decreased expression of PRKCA mRNA | decreases expression | 11091364
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of PRKCA mRNA | increases expression | 19101580
|
D014635 |
Valproic Acid |
Valproic Acid results in decreased expression of PRKCA protein | decreases expression | 15249158
|
D014638 |
Vanadates |
[Hydrogen Peroxide co-treated with Vanadates] results in increased phosphorylation of [PLD1 protein binds to PRKCA protein] | affects binding|affects cotreatment|increases phosphorylation | 15150437
|
D014638 |
Vanadates |
[Hydrogen Peroxide co-treated with Vanadates] results in increased phosphorylation of PRKCA protein | affects cotreatment|increases phosphorylation | 15150437
|
D014639 |
Vanadium |
PRKCA protein affects the reaction [Vanadium results in increased phosphorylation of and results in increased activity of AKT1 protein] | affects reaction|increases activity|increases phosphorylation | 14971662
|
D014639 |
Vanadium |
PRKCA protein affects the reaction [Vanadium results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | affects reaction|increases activity|increases phosphorylation | 14971662
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
3.68 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
22.41 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Capsaicin |
22.41 | 18926900 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
22.41 | 17676605 18926900 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
22.41 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
22.41 | 11752688 14514962 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
22.41 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.16 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
7.67 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
7.67 | 11192467 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.08 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
Capsaicin |
10.34 | 18460982 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
10.34 | 16538975 |
MESH:D058186 |
Acute Kidney Injury |
|
Superoxides |
10.34 | 18460982 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
6.43 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
6.43 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
15.93 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
daidzein |
15.93 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
15.93 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
15.93 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
15.93 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
15.93 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Urethane |
15.93 | 18316556 |
MESH:D002282 |
Adenocarcinoma, Bronchiolo-Alveolar |
|
Urethane |
4.85 | 15814487 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
11.38 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
11.38 | 10737359 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
11.38 | 15688382 |
MESH:D000236 |
Adenoma |
|
Urethane |
11.38 | 10530776 10822126 17195641 6695378 17093202 16926031 11497255 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
17.98 | 19061943 17162532 19052882 16434500 17620307 18056438 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
17.98 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
17.98 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
17.98 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
3.84 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.04 | 16712894 17306315 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Atrazine |
6.67 | 11874814 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Heptachlor |
6.67 | 12661182 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
3.73 | 21441931 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.45 | 15451039 15451040 |
MESH:D019973 |
Alcohol-Related Disorders |
|
Curcumin |
4.22 | 17887948 |
MESH:D000505 |
Alopecia |
|
Capsaicin |
7.24 | 17569567 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
7.24 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Curcumin |
5.07 | 15590663 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
5.07 | 16162502 16183991 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
5.07 | 19621015 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.37 | 17688650 |
MESH:D019969 |
Amphetamine-Related Disorders |
|
Amphetamine |
5.21 | 16459022 16916582 18475255 15010207 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
3.67 | 15469931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.20 | 11748828 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Superoxides |
4.85 | 16910769 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
3.99 | 15513904 |
MESH:D000855 |
Anorexia |
|
Amphetamine |
4.26 | 12005258 16101753 16084549 12183048 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
6.66 | 11141031 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
6.66 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.24 | 19183758 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
3.37 | 17460149 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
7.17 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
7.17 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
12.69 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
12.69 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
12.69 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
12.69 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Curcumin |
3.74 | 16807698 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
3.74 | 16292516 |
MESH:D001249 |
Asthma |
|
fluticasone |
4.43 | 11596838 11991558 11101185 |
MESH:D001249 |
Asthma |
|
Tretinoin |
4.43 | 16456186 |
MESH:D001259 |
Ataxia |
|
1-Butanol |
4.79 | 7820390 |
MESH:D050197 |
Atherosclerosis |
|
Curcumin |
5.02 | 18704882 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
5.02 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.18 | 20603192 18775368 15238991 17157402 18316065 19460635 17507914 16609825 18558336 19232924 17688650 18396377 18940202 18177632 18985861 |
MESH:D001327 |
Autoimmune Diseases |
|
Curcumin |
3.67 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.59 | 16935849 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.57 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
10.83 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
10.83 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
10.83 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
2.93 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
6.00 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
6.00 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
3.84 | 14601052 |
MESH:D001919 |
Bradycardia |
|
Capsaicin |
8.11 | 18207255 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
8.11 | 15306635 |
MESH:D001930 |
Brain Injuries |
|
Pregnanolone |
5.38 | 15665606 15380490 |
MESH:D002545 |
Brain Ischemia |
|
Capsaicin |
12.32 | 19211983 |
MESH:D002545 |
Brain Ischemia |
|
Curcumin |
12.32 | 16770732 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
12.32 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Curcumin |
6.48 | 17596214 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
6.48 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
11.41 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Cacodylic Acid |
11.41 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Curcumin |
11.41 | 19250217 16243823 18462866 18593918 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
11.41 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
11.41 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
11.41 | 17129689 15324884 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
11.41 | 16096432 16115903 16264153 18234424 19526202 18382427 18628466 16826403 15939500 15136595 18695136 16322301 17369602 17426702 17983394 15567936 15668708 15994142 15634643 15692762 16935488 11325840 15993339 16595493 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
11.41 | 19861407 12948864 17289903 18497071 17018787 16675129 17261762 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
11.41 | 16541309 16873071 17200150 |
MESH:D001943 |
Breast Neoplasms |
|
Heptachlor |
11.41 | 8738476 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
11.41 | 17534123 16393696 17651959 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
11.41 | 19289846 20544844 20859285 11161223 15668708 19011961 19084267 19155303 20005174 17893378 17261762 20065188 21152245 18351453 18984771 20135344 18425577 19066611 17049068 19189210 19410462 16818667 16873071 19221464 21138602 19059307 20390343 18997820 17440819 16273361 19200415 19142967 19103187 17242785 19487384 19115204 19288272 18815881 18821012 15565566 19244106 16202921 19189212 18629630 18855134 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
11.41 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
11.41 | 16166294 16443354 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
Vanadium |
11.41 | 15565634 |
MESH:D029481 |
Bronchitis, Chronic |
|
fluticasone |
5.85 | 17687719 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
3.74 | 16813970 |
MESH:D002056 |
Burns |
|
Ethanol |
3.82 | 16374292 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.61 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
3.95 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Curcumin |
5.96 | 18593918 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
5.96 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
3.67 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.29 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
23.28 | 16502159 19519916 18210153 16830150 19052882 19171122 20727157 17162532 18691550 11831363 17761372 21159647 18788625 18494052 16681979 17428255 16569478 18506893 17055752 20101231 18393292 20007298 3084413 16288022 18971187 20935162 16328049 17173139 18665156 16779866 20514400 16540662 19418558 17138121 16878318 20524982 19919837 19822196 19208518 20512989 16935385 19539802 18056438 18978308 20214788 16807293 10672840 18785209 20432363 19394651 10737359 19335982 16698587 3581430 17978847 19383236 20084675 19107877 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
23.28 | 16924424 15948411 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
23.28 | 16234567 18059187 16023760 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
23.28 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
23.28 | 18788625 15763234 15289165 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
23.28 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
23.28 | 17173139 1701930 20935162 20007298 6705139 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
23.28 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
23.28 | 15276417 16507464 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
23.28 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
23.28 | 1917145 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Vanadium |
23.28 | 16830150 16878318 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
3.75 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Curcumin |
2.61 | 18414057 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
2.69 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
16.56 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Curcumin |
16.56 | 18462866 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
16.56 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
16.56 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
16.56 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
16.56 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
16.56 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
2.86 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
8.30 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
8.30 | 15728586 17124262 17287366 11754973 11179087 16170337 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
8.30 | 16120746 18670907 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
2.92 | 16242529 16651473 16612575 17519947 17974986 17131338 17007740 17351982 16455267 17308081 17924179 18627295 16109756 16364871 16952015 16731534 16278810 17329180 15505089 15476868 16269455 17928571 17382496 15811867 15792986 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.57 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Aldosterone |
16.05 | 11230374 |
MESH:D002318 |
Cardiovascular Diseases |
|
daidzein |
16.05 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
16.05 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
16.05 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
16.05 | 15458977 |
MESH:D020212 |
Carotid Artery Injuries |
|
tetracycline CMT-3 |
5.71 | 14507662 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
9.33 | 14694615 |
MESH:D002386 |
Cataract |
|
Adenosine Triphosphate |
9.33 | 15003327 |
MESH:D002386 |
Cataract |
|
Tretinoin |
9.33 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
18.20 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
18.20 | 17174075 2727394 21159647 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
18.20 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
monomethylarsonous acid |
18.20 | 19716837 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
18.20 | 20056578 19524636 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Vanadium |
18.20 | 17174075 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.42 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
3.74 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.32 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
6.88 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
6.88 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
5.52 | 17681005 16105132 17110522 16919318 11677210 15861022 17333356 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
5.52 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.29 | 16461808 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.06 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
10.40 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
10.40 | 15340226 16354765 15668235 12621046 8697196 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
10.40 | 9407595 |
MESH:D002972 |
Cleft Palate |
|
Urethane |
10.40 | 12810352 |
MESH:D003092 |
Colitis |
|
Curcumin |
11.34 | 18200517 16804969 16782535 |
MESH:D003092 |
Colitis |
|
resveratrol |
11.34 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
11.34 | 17035595 |
MESH:D003103 |
Coloboma |
|
Curcumin |
3.77 | 18809619 |
MESH:D003110 |
Colonic Neoplasms |
|
Curcumin |
13.29 | 19359593 16340194 |
MESH:D003110 |
Colonic Neoplasms |
|
Deoxycholic Acid |
13.29 | 16213893 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
13.29 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
13.29 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
13.29 | 17287894 17725105 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
13.29 | 16338953 |
MESH:D003110 |
Colonic Neoplasms |
|
Vanadium |
13.29 | 18155637 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.88 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.88 | 18259882 18509181 17159606 17454858 16391804 16303861 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.88 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
6.75 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
6.75 | 17141729 14669216 |
MESH:D016510 |
Corneal Neovascularization |
|
Curcumin |
4.06 | 18497527 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.15 | 16507316 |
MESH:D003371 |
Cough |
|
Capsaicin |
4.32 | 10350223 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
9.23 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
9.23 | 15451040 19302082 10194807 15451039 15513904 11873399 11198716 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Lead |
9.23 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
lead acetate |
9.23 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
9.23 | 15322242 20055451 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
9.23 | 9125849 14991402 17551590 9224671 10589399 16925845 8800419 9142499 9211117 9664655 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
9.23 | 16575769 8888407 17688650 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
3.75 | 12952375 16002989 |
MESH:D003704 |
Dementia |
|
Lead |
4.48 | 16140633 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.53 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
2.65 | 12438553 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
1.95 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
3.57 | 17446233 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.06 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Curcumin |
13.12 | 18403477 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
daidzein |
13.12 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
13.12 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
13.12 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
13.12 | 12642470 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
13.12 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Curcumin |
15.44 | 18204486 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
15.44 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
15.44 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
15.44 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Pregnanolone |
5.61 | 17187935 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
2.92 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
13.18 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
bicyclol |
13.18 | 15998439 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
13.18 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
13.18 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
13.18 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
13.18 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
13.18 | 19641884 1733752 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
5.89 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
5.89 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
Capsaicin |
6.96 | 11535926 10671773 |
MESH:D004381 |
Duodenal Ulcer |
|
Curcumin |
6.96 | 17351913 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
2.80 | 18367378 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
7.81 | 1851702 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
7.81 | 1851702 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
3.65 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
21.08 | 19703484 |
MESH:D004487 |
Edema |
|
pirinixic acid |
21.08 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
21.08 | 8985016 |
MESH:D004487 |
Edema |
|
rosiglitazone |
21.08 | 12083418 |
MESH:D004487 |
Edema |
|
Staurosporine |
21.08 | 8273558 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
21.08 | 12711302 11000095 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
21.08 | 16716910 9599246 7812673 8273558 11698051 15177302 8113982 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
9.08 | 16714409 15322242 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
9.08 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
10.71 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
10.71 | 17872969 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
10.71 | 19031437 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
9.08 | 16402032 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
9.08 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
daidzein |
25.72 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
25.72 | 15700306 16804899 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
25.72 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
25.72 | 18566989 19148513 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
25.72 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
25.72 | 16202921 20544844 17893378 19155303 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
25.72 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Mifepristone |
6.66 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
6.66 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.29 | 18037988 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
3.55 | 15328337 15821434 17637181 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.02 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
8.05 | 3659116 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
8.05 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
7.13 | 3922381 11558140 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
7.13 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
4.93 | 20417680 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
4.93 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
6.43 | 6401628 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
6.43 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
8.55 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
8.55 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
7.68 | 3659116 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
7.68 | 3659116 |
MESH:D007172 |
Erectile Dysfunction |
|
daidzein |
4.21 | 14972507 |
MESH:D004892 |
Erythema Multiforme |
|
Thiram |
5.78 | 16750123 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.25 | 16302075 |
MESH:D004935 |
Esophageal Diseases |
|
Capsaicin |
4.85 | 19566590 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
5.40 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
5.40 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
5.40 | 16704527 |
MESH:D004942 |
Esophagitis, Peptic |
|
Bile Acids and Salts |
5.69 | 11346197 |
MESH:D020329 |
Essential Tremor |
|
Lead |
5.08 | 14594619 18007985 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
6.59 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
6.59 | 16938888 9664655 |
MESH:D005221 |
Fatigue |
|
Amphetamine |
4.75 | 19890266 |
MESH:D005234 |
Fatty Liver |
|
bicyclol |
39.71 | 16409862 |
MESH:D005234 |
Fatty Liver |
|
Curcumin |
39.71 | 19297423 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
39.71 | 17967931 19004024 18296743 19551842 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
39.71 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
39.71 | 19236843 16409862 18620774 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
39.71 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
39.71 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
39.71 | 19196556 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
39.71 | 14986274 19224547 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
39.71 | 19224547 14986274 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
4.80 | 17920746 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
6.26 | 16611131 15751030 16534752 16513791 16002989 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
6.26 | 16709447 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.45 | 10194807 15451040 15513904 16946407 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.63 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.02 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Lead |
13.89 | 19769572 |
MESH:D005317 |
Fetal Growth Retardation |
|
lead acetate |
13.89 | 19769572 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
13.89 | 8888407 18558336 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.27 | 9205823 11852909 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
3.68 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
8.63 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
8.63 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Curcumin |
14.46 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
14.46 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.46 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
14.46 | 17994277 |
MESH:D005756 |
Gastritis |
|
Ethanol |
3.83 | 15046732 |
MESH:D005770 |
Gastrointestinal Neoplasms |
|
Curcumin |
3.86 | 18462866 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
10.00 | 16452187 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
10.00 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Capsaicin |
15.81 | 18405923 |
MESH:D005909 |
Glioblastoma |
|
Curcumin |
15.81 | 17596214 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
15.81 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
15.81 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
15.81 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.73 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Curcumin |
9.38 | 18462866 18829502 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
9.38 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
9.38 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.29 | 16084493 |
MESH:D006356 |
Heartburn |
|
Capsaicin |
4.85 | 19566590 |
MESH:D006330 |
Heart Defects, Congenital |
|
3,4,3',4'-tetrachlorobiphenyl |
11.68 | 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
11.68 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
11.68 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
11.68 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
5.98 | 16330681 18006777 18674790 17875725 16707910 12587719 16879835 17888722 16495754 16244371 16244372 16144979 14766674 |
MESH:D006331 |
Heart Diseases |
|
Urethane |
5.98 | 16046796 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
5.09 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
5.09 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.14 | 15692506 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
3.63 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.56 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
9.64 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.64 | 18467677 19772884 16221962 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.64 | 16120746 12621046 15340226 |
MESH:D015417 |
Hereditary Sensory and Motor Neuropathy |
|
Curcumin |
4.21 | 17701891 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
2.69 | 7520565 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.17 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.34 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
5.09 | 17606976 18501091 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
5.09 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
2.90 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.02 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.18 | 8697196 18606429 16354765 16959395 15340226 |
MESH:D006930 |
Hyperalgesia |
|
Capsaicin |
13.07 | 17434803 17043245 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
13.07 | 18783367 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
13.07 | 12083418 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
13.07 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Curcumin |
10.93 | 18704882 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
10.93 | 21332399 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
10.93 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.74 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.43 | 20558911 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Superoxides |
4.54 | 12615666 |
MESH:D006948 |
Hyperkinesis |
|
Amphetamine |
4.59 | 14960337 1977408 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
6.68 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
6.68 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
3.61 | 14722030 12960047 |
MESH:D006967 |
Hypersensitivity |
|
Butylated Hydroxytoluene |
3.77 | 17604070 |
MESH:D006973 |
Hypertension |
|
daidzein |
8.98 | 17169123 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
8.98 | 17042910 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
8.98 | 8949925 12717712 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.98 | 18850075 18670907 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
3.78 | 18502941 12791704 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.55 | 17488730 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
8.49 | 16002989 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
8.49 | 16945680 16569931 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
3.82 | 17600658 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
8.59 | 15036965 |
MESH:D007246 |
Infertility |
|
Thiram |
8.59 | 6420938 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.67 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Atrazine |
11.05 | 12948887 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
11.05 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Lead |
11.05 | 16780224 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
11.05 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Capsaicin |
29.78 | 16956363 |
MESH:D007249 |
Inflammation |
|
Curcumin |
29.78 | 16956363 18403477 17151092 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
29.78 | 8960868 11099482 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
29.78 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
29.78 | 18785209 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
29.78 | 12878042 9205823 17255318 17237260 17963957 |
MESH:D007249 |
Inflammation |
|
resveratrol |
29.78 | 16366677 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
29.78 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
29.78 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
29.78 | 12878042 12200463 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
29.78 | 8273558 11698051 15177302 7562506 7812673 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Curcumin |
2.79 | 18200517 18596194 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
3.69 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
12.63 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
12.63 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
12.63 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
12.63 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Superoxides |
7.56 | 10210152 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
7.56 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
Curcumin |
3.47 | 10783313 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
3.84 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
12.73 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
12.73 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
12.73 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.91 | 15369732 15699352 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.91 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.91 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
7.56 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
7.56 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
8.37 | 14681315 16762066 15003126 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
8.37 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
8.37 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.18 | 16316344 |
MESH:D007855 |
Lead Poisoning |
|
Lead |
5.08 | 16700817 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
11.54 | 17184923 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
11.54 | 15451040 |
MESH:D007859 |
Learning Disorders |
|
Lead |
11.54 | 16384672 |
MESH:D007889 |
Leiomyoma |
|
Curcumin |
3.78 | 18555241 |
MESH:D007938 |
Leukemia |
|
Curcumin |
7.58 | 18462866 |
MESH:D007938 |
Leukemia |
|
Genistein |
7.58 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
7.58 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.29 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Curcumin |
3.44 | 16106398 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
PD 98059 |
4.38 | 16972261 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
2.93 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.10 | 19850784 16294345 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.10 | 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
5.72 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
5.72 | 17294898 17506722 19642359 19075265 19035177 12679006 17649720 17361223 16788101 16891316 17107899 19029980 15748426 16935935 9834237 17301526 16823087 19225113 17368321 17217047 16331271 16140955 17339181 17712046 16766008 |
MESH:D015458 |
Leukemia, T-Cell |
|
Curcumin |
3.95 | 16106398 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
3.85 | 15821434 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
6.14 | 17676605 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
6.14 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.51 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
11.28 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
11.28 | 18665156 19638242 18522880 20032147 18407596 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
11.28 | 15289165 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
11.28 | 21047994 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.25 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
bicyclol |
23.56 | 15730626 16603200 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Curcumin |
23.56 | 17355460 18705752 18006644 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
23.56 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
23.56 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
23.56 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
23.56 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
fasudil |
23.56 | 17761835 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
23.56 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
23.56 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
23.56 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
23.56 | 17347453 15980055 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
23.56 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
23.56 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
23.56 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Capsaicin |
6.80 | 16956363 |
MESH:D008107 |
Liver Diseases |
|
Curcumin |
6.80 | 16956363 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
6.80 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
6.80 | 19363144 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
3.82 | 17347304 17207112 |
MESH:D008113 |
Liver Neoplasms |
|
2,4,5,2',4',5'-hexachlorobiphenyl |
35.63 | 16835634 18644402 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
35.63 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Butylated Hydroxytoluene |
35.63 | 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
35.63 | 19294768 10737359 18754104 20492335 20501860 19833225 21071580 20405173 2422723 19996281 19812893 20583210 19551842 9163691 19642983 19638242 18644402 12112319 18648771 19256749 19254457 21278145 20101389 12771043 19090486 19690152 2862719 21167192 20452335 19499222 18978307 19427195 15175105 16942905 18977376 20434301 20118626 19426721 19850985 21047994 19255062 19073162 20137499 15885732 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
35.63 | 15890375 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Heptachlor |
35.63 | 9544696 2422723 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
35.63 | 8742319 15975961 19073162 19482888 21047994 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
35.63 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
35.63 | 19812893 19321006 19073162 20405173 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
35.63 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
35.63 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
35.63 | 16984957 |
MESH:D008113 |
Liver Neoplasms |
|
Urethane |
35.63 | 17093202 16391232 17559639 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Deoxycholic Acid |
15.74 | 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
15.74 | 18544905 18093689 17174075 18282651 18775883 19519916 2563599 18308698 19009564 17854601 19004024 16842330 9362446 18253720 16267830 18164116 19539802 21159647 18079962 3124819 17942915 19126423 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
15.74 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
15.74 | 2563599 17172636 6150874 1399818 18308698 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
15.74 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Vanadium |
15.74 | 17174075 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.56 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.40 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
6.58 | 17365036 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
6.58 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
16.04 | 18569708 18816296 20464547 20869020 18520028 20064080 17053015 6695378 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Butylated Hydroxytoluene |
16.04 | 19359593 11246140 18597497 16337739 11696405 15390079 19925653 |
MESH:D008175 |
Lung Neoplasms |
|
Curcumin |
16.04 | 18462866 16243823 19359593 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
16.04 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
16.04 | 6695378 20970405 20512841 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
16.04 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
16.04 | 17077188 17306315 19931552 16712894 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
16.04 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
16.04 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
16.04 | 11807781 |
MESH:D008175 |
Lung Neoplasms |
|
Urethane |
16.04 | 12957351 11323394 17255336 16337739 11992545 15136453 11807781 10997738 11544531 10530776 12466968 16788158 16289808 11307925 15166089 16007126 12765245 17093202 16204055 16391232 11497255 17195641 10822126 11246140 11893704 11552296 6695378 10779650 15902970 16926031 12117781 7750092 14587096 11062179 11074608 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.30 | 15166399 |
MESH:D008223 |
Lymphoma |
|
Curcumin |
8.89 | 18462866 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
8.89 | 15700306 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
8.89 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
3.51 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
6.50 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
6.50 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Curcumin |
8.81 | 16173963 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
8.81 | 15621674 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
4.65 | 16002989 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
7.21 | 15688416 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
7.21 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Butylated Hydroxytoluene |
26.78 | 1500032 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Corticosterone |
26.78 | 12807724 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
26.78 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
26.78 | 17203775 16891317 11408345 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
26.78 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
26.78 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
26.78 | 16827153 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
26.78 | 14580682 19196723 11731420 16827153 19196722 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
26.78 | 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
9.78 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
9.78 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.36 | 17453147 |
MESH:D008545 |
Melanoma |
|
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline |
11.61 | 16077934 |
MESH:D008545 |
Melanoma |
|
Curcumin |
11.61 | 17885582 18462866 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
11.61 | 16827129 |
MESH:D008545 |
Melanoma |
|
resveratrol |
11.61 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
11.61 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
11.61 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
11.61 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.34 | 15990972 |
MESH:D008569 |
Memory Disorders |
|
Curcumin |
11.52 | 17263510 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
11.52 | 18411066 15451040 |
MESH:D008569 |
Memory Disorders |
|
Lead |
11.52 | 17263510 16384672 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.59 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
7.81 | 18303189 16966607 16166281 |
MESH:D008654 |
Mesothelioma |
|
Atrazine |
7.81 | 1916698 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
7.81 | 17638057 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.60 | 17112576 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
3.66 | 17261469 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.55 | 18803445 18765137 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
3.72 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.51 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
9.61 | 17415656 |
MESH:D052016 |
Mucositis |
|
irinotecan |
9.61 | 17159606 |
MESH:D009101 |
Multiple Myeloma |
|
Capsaicin |
12.04 | 17505005 |
MESH:D009101 |
Multiple Myeloma |
|
Curcumin |
12.04 | 19372569 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
12.04 | 15867202 15744524 16118317 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
12.04 | 16490592 17049120 16267019 17164350 14749477 17935668 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
Curcumin |
9.60 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
9.60 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.68 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.25 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
9.10 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
9.10 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
9.10 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
9.85 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
9.85 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
9.85 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
9.85 | 16317513 17188708 16456233 16525036 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
6.67 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
6.67 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
10.21 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
10.21 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
10.21 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
3.91 | 17322642 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
3.63 | 17484760 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Curcumin |
8.34 | 18495463 |
MESH:D009361 |
Neoplasm Invasiveness |
|
tetracycline CMT-3 |
8.34 | 11172680 11172682 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
9.99 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
9.99 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
9.99 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
9.99 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.16 | 19410462 |
MESH:D009369 |
Neoplasms |
|
2,4,5,2',4',5'-hexachlorobiphenyl |
16.29 | 8820588 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
16.29 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
16.29 | 15313581 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
16.29 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
16.29 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
16.29 | 16594593 16946489 |
MESH:D009369 |
Neoplasms |
|
Urethane |
16.29 | 15625555 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
10.69 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
10.69 | 20056578 |
MESH:D009374 |
Neoplasms, Experimental |
|
Urethane |
10.69 | 15582191 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Curcumin |
7.99 | 12497104 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
7.99 | 19189210 19196722 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
2.89 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
3.94 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.27 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
22.26 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
22.26 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
22.26 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
22.26 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
22.26 | 9125849 |
MESH:D009423 |
Nervous System Neoplasms |
|
Curcumin |
4.76 | 18462866 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
8.60 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
8.60 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
8.60 | 16359493 8888407 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
5.42 | 15555623 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
5.42 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Amphetamine |
10.16 | 15183010 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
10.16 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
10.16 | 17652729 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
3.88 | 8761367 |
MESH:D020078 |
Neurogenic Inflammation |
|
Capsaicin |
8.34 | 17961222 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
8.34 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.25 | 20387270 |
MESH:D009765 |
Obesity |
|
Capsaicin |
8.08 | 19056576 |
MESH:D009765 |
Obesity |
|
Curcumin |
8.08 | 19297423 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
8.08 | 21332399 20132043 18457598 18674790 16723640 19632207 17217161 11836018 20518802 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
8.08 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
3.35 | 14694615 |
MESH:D010009 |
Osteochondrodysplasias |
|
Thiram |
4.85 | 17954590 15518828 15899490 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
3.52 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
8.59 | 17882678 |
MESH:D010024 |
Osteoporosis |
|
Curcumin |
8.59 | 18719352 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
8.59 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
7.53 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
7.53 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.41 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline |
20.56 | 16211241 |
MESH:D010051 |
Ovarian Neoplasms |
|
Curcumin |
20.56 | 19020741 18462866 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
20.56 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
20.56 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Mifepristone |
20.56 | 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
20.56 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
20.56 | 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
Urethane |
20.56 | 16391232 |
MESH:D010146 |
Pain |
|
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione |
7.62 | 18987195 |
MESH:D010146 |
Pain |
|
Capsaicin |
7.62 | 16996476 17043245 18987195 19081190 17434803 17084039 |
MESH:D010146 |
Pain |
|
Tretinoin |
7.62 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Curcumin |
15.20 | 19196508 19401701 17440100 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
15.20 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
15.20 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
15.20 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
15.20 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
15.20 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
2.89 | 11578682 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
6.89 | 12065085 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
6.89 | 12065085 18404319 8330346 18922899 |
MESH:D010300 |
Parkinson Disease |
|
Atrazine |
2.90 | 17218051 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.38 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.29 | 17983394 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.30 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
9.38 | 15687265 16977796 |
MESH:D010911 |
Pituitary Neoplasms |
|
Urethane |
9.38 | 16391232 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.06 | 10923243 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.29 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Butylated Hydroxytoluene |
8.58 | 11893704 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
8.58 | 12224865 11605937 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
2.75 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
6.65 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
6.65 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.00 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
21.63 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Lead |
21.63 | 16384672 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
21.63 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
21.63 | 11222880 11399792 11118676 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
21.63 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.11 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
4.71 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Curcumin |
4.71 | 15129424 10851300 12497104 18226269 18769126 18156803 11398177 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
4.71 | 15846301 17136230 15046698 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
4.71 | 15749863 18437689 16888761 15897917 16729912 16868541 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
4.71 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
4.71 | 15378649 15256057 16925846 |
MESH:D011471 |
Prostatic Neoplasms |
|
Heptachlor |
4.71 | 12661182 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
4.71 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
4.71 | 17804756 17718901 17675339 16731767 17636462 15767336 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
4.71 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
4.71 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
tetracycline CMT-3 |
4.71 | 11857423 11172682 |
MESH:D011471 |
Prostatic Neoplasms |
|
Thiram |
4.71 | 19789329 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
2.82 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.48 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
9.33 | 12752131 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
9.33 | 12752131 11422049 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
3.94 | 16723453 |
MESH:D011656 |
Pulmonary Emphysema |
|
Curcumin |
3.77 | 19168576 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
2.63 | 15814490 17365031 17975199 17322281 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.40 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.72 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
Capsaicin |
11.58 | 18460982 19211983 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
11.58 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
11.58 | 15827377 16314181 16317513 17058453 17520802 |
MESH:D015427 |
Reperfusion Injury |
|
Superoxides |
11.58 | 18460982 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Curcumin |
6.70 | 10666014 18379247 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
6.70 | 11700416 18379247 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.12 | 10835634 |
MESH:D012135 |
Respiratory Sounds |
|
Atrazine |
3.70 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.02 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
8.23 | 16283617 16116481 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
8.23 | 19155313 |
MESH:D012509 |
Sarcoma |
|
Curcumin |
7.07 | 18462866 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
7.07 | 16767912 17203757 17710206 15675481 15625365 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
3.44 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
3.94 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
1.93 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Ethanol |
6.33 | 9754883 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
6.33 | 3137016 11442880 16876388 4039156 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
6.33 | 11044598 16876388 3137016 1511512 11738929 14763951 17978042 15475178 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
3.97 | 6407741 |
MESH:D018805 |
Sepsis |
|
Curcumin |
7.63 | 18389075 |
MESH:D018805 |
Sepsis |
|
tetracycline CMT-3 |
7.63 | 15489642 16003065 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
3.86 | 7327846 |
MESH:D012871 |
Skin Diseases |
|
monomethylarsonic acid |
4.79 | 21378128 |
MESH:D012871 |
Skin Diseases |
|
monomethylarsonous acid |
4.79 | 17431481 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
31.33 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
31.33 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
31.33 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
31.33 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
31.33 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
31.33 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
31.33 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
31.33 | 12065085 8985016 8330346 11807781 18404319 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
31.33 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
Urethane |
31.33 | 11807781 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
3.74 | 15625365 17203757 16767912 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
15.17 | 16709447 16002989 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
15.17 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
15.17 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.19 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
7.25 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
7.25 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
3.68 | 12833885 |
MESH:D019956 |
Stereotypic Movement Disorder |
|
Amphetamine |
5.56 | 1977408 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
3.48 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
4.84 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
4.84 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
4.84 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
4.84 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.84 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Curcumin |
7.82 | 19188055 16631530 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
7.82 | 15138204 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
7.82 | 9562338 11906479 17189318 17918041 9211565 16755016 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.72 | 16321402 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
3.50 | 9754883 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
Capsaicin |
4.86 | 17997062 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.41 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
2.83 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.42 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.04 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
11.57 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
11.57 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
11.57 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
11.57 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
3.82 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
7.41 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
7.41 | 16051514 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.37 | 17262798 |
MESH:D014202 |
Tremor |
|
Lead |
4.63 | 21145352 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.64 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
3.67 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
20.89 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cacodylic Acid |
20.89 | 15537745 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Curcumin |
20.89 | 18593936 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
20.89 | 16712894 17306315 16452187 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
20.89 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
monomethylarsonous acid |
20.89 | 20375083 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
20.89 | 17306315 16452187 16712894 11723127 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
20.89 | 16712894 17572228 8653321 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
3.81 | 8888407 |
MESH:D014565 |
Urogenital Neoplasms |
|
Curcumin |
4.41 | 18462866 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
16.50 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
16.50 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
16.50 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
16.50 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
4.30 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
11.42 | 15809267 16690809 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
11.42 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
11.42 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
3.75 | 16752155 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
3.96 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
3.61 | 16002989 16513791 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.58 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.73 | 12125929 |
MESH:D019043 |
Vascular Neoplasms |
|
Urethane |
5.05 | 10620525 |
MESH:D020301 |
Vasospasm, Intracranial |
|
fasudil |
5.88 | 19057314 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
2.77 | 15869587 14671159 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
7.60 | 17334414 17678736 16364871 17638931 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
7.60 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.25 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.38 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.00 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.23 | 16287080 |